ARCpoint Inc. has been issued a failure-to-file cease trade order by the British Columbia Securities Commission due to missing its July 29, 2026 deadline to file audited annual financial statements and related documents for the year ended March 31, 2026. This order suspends all trading of ARCpoint's shares until the filings are completed and the order is revoked. The delay is caused by the company's lack of funds to pay auditors and accounting staff. ARCpoint is working to secure financing to complete the audit and resume trading but has not provided a revised filing date yet.
Tarsus Pharmaceuticals announced it will host a live webcast on August 6, 2026, to report its second quarter financial results and provide a corporate update. The webcast will be available at 5:00 a.m. PT / 8:00 a.m. ET, with a recorded version acces...
Kirby McInerney LLP is investigating Myriad Genetics for possible securities fraud following the company's report of an 11% revenue decline in Q2 2026 and a lowered full-year revenue forecast. The company also disclosed an $11 million revenue reducti...
Kirby McInerney LLP is investigating Dr. Reddy's Laboratories for possible securities fraud following the company's Q1 fiscal 2027 earnings report, which revealed an earnings miss and a ₹2.4 billion provision related to out-of-spec semaglutide batche...
Jefferies Financial Group is under investigation by Kirby McInerney LLP for potential securities law violations related to its asset-management unit's exposure to First Brands Group, which declared bankruptcy in 2025. The SEC is reportedly probing wh...
FREELANDER 8, a British premium intelligent all-terrain vehicle co-developed by Chery and Jaguar Land Rover, has started mass production at the Chery Jaguar Land Rover Changshu Manufacturing Base. This advanced facility, with over 1,100 intelligent r...
